Testing version — LOERadar is in active testing. Features and data may change.
ARICEPT ODT (DONEPEZIL HYDROCHLORIDE) | LOERadar
ARICEPT ODT
NDA
DONEPEZIL HYDROCHLORIDE | N021720 | EISAI INC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 5MG
RLD
0 patents0 exclusivities▴
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Oct 18, 2004
No patent or exclusivity listings for this strength.
#002 — 10MG
RLD
0 patents0 exclusivities▾
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Oct 18, 2004